Evidence mapPaperPMID 40647220Full record

ArticleNutrients2025

Obesity-Associated NAFLD Coexists with a Chronic Inflammatory Kidney Condition That Is Partially Mitigated by Short-Term Oral Metformin.

Amod Sharma, Reza Hakkak, Neriman Gokden, Neelam Joshi, Nirmala Parajuli

Abstract read
In one paragraph

Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amod SharmaDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.ORCID 0000-0002-2860-7790
Reza HakkakDepartment of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.ORCID 0000-0003-4829-8478
Neriman GokdenDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Neelam JoshiDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Nirmala ParajuliDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.ORCID 0000-0003-3994-5338

Funding

Arkansas Bioscience Institute ACRI 037122NIH HHS 1R01DK123264-26
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hypoglycemic AgentsMetforminNon-alcoholic Fatty Liver DiseaseObesityRenal Insufficiency, ChronicAdministration, OralAnimalsChemokine CCL2Disease Models, AnimalFemaleInflammationKidneyOxidative StressRatsRats, ZuckerTumor Necrosis Factor-alphaChemokine CCL2Hypoglycemic AgentsMetforminTumor Necrosis Factor-alphainflammationkidney injurymetforminobesity-NAFLDoxidative stress

Identifiers

PMID40647220
PMCPMC12251041

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.